New research shows the keto diet, used to treat neurological and metabolic diseases, suppresses bifidobacteria and Th17 cells
15 Jun 2020by Andreu Prados
Could the keto diet’s therapeutic benefits be linked to changes in the gut microbiota? New work in mice and 17 men who are overweight or obese reveals ketone bodies exert suppression of bifidobacteria and intestinal pro-inflammatory Th17 cells.